Childhood Cancer Incidence, New York State Excl New York City, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI | Avg Annual Cases | Rate per 1,000,000 | 95% CI | |
| All Invasive Malignant Tumors | 148.6 | 245.0 | 82.8 | 130.1 | 122.2 | 183.4 | 203.0 | 273.0 | 353.6 | 185.4 | 176.9-194.3 | 556.6 | 207.5 | 199.8-215.4 |
| I Leukemias, myeloproliferative and myelodysplastic diseases | 46.8 | 77.1 | 23.4 | 36.8 | 22.2 | 33.3 | 27.0 | 36.3 | 92.4 | 48.5 | 44.2-53.1 | 119.4 | 45.4 | 41.9-49.2 |
| I(a) Lymphoid leukemias | 36.6 | 60.3 | 19.4 | 30.5 | 12.6 | 18.9 | 11.2 | 15.1 | 68.6 | 36.0 | 32.3-40.1 | 79.8 | 30.8 | 27.8-33.9 |
| I(b) Acute myeloid leukemia | 8.0 | 13.2 | 2.2 | 3.5 | 6.8 | 10.2 | 9.0 | 12.1 | 17.0 | 8.9 | 7.1-11.0 | 26.0 | 9.7 | 8.1-11.5 |
| II Lymphomas and reticuloendothelial neoplasms | 11.0 | 18.1 | 11.8 | 18.5 | 22.4 | 33.6 | 45.6 | 61.3 | 45.2 | 23.6 | 20.6-26.8 | 90.8 | 33.1 | 30.1-36.3 |
| II(a) Hodgkin lymphoma | 0.4 | 0.7 | 1.4 | 2.2 | 10.4 | 15.6 | 29.6 | 39.8 | 12.2 | 6.3 | 4.8-8.1 | 41.8 | 14.7 | 12.8-16.8 |
| II(b,c,d) Non-Hodgkin lymphomas | 10.6 | 17.5 | 10.4 | 16.3 | 12.0 | 18.0 | 15.8 | 21.3 | 33.0 | 17.3 | 14.7-20.1 | 48.8 | 18.3 | 16.1-20.7 |
| III CNS & misc intracranial & intraspinal neoplasms | 28.6 | 47.1 | 26.2 | 41.2 | 22.2 | 33.3 | 16.0 | 21.5 | 77.0 | 40.5 | 36.5-44.7 | 93.0 | 35.7 | 32.5-39.1 |
| III(a) Ependymomas and choroid plexus tumor | 4.0 | 6.6 | 2.2 | 3.5 | 0.8 | 1.2 | 1.2 | 1.6 | 7.0 | 3.7 | 2.6-5.2 | 8.2 | 3.2 | 2.3-4.3 |
| III(b) Astrocytoma | 13.4 | 22.1 | 14.4 | 22.6 | 12.2 | 18.3 | 10.2 | 13.7 | 40.0 | 21.0 | 18.2-24.1 | 50.2 | 19.2 | 16.9-21.7 |
| III(c) Intracranial and intraspinal embryonal tumors | 7.8 | 12.9 | 4.0 | 6.3 | 3.2 | 4.8 | 1.0 | 1.3 | 15.0 | 7.9 | 6.2-9.9 | 16.0 | 6.3 | 5.0-7.8 |
| III(d) Other gliomas | 2.6 | 4.3 | 5.4 | 8.5 | 5.4 | 8.1 | 3.0 | 4.0 | 13.4 | 7.0 | 5.4-8.9 | 16.4 | 6.3 | 5.0-7.8 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 21.0 | 34.6 | 2.4 | 3.8 | 0.8 | 1.2 | 0.6 | 0.8 | 24.2 | 13.0 | 10.7-15.5 | 24.8 | 9.9 | 8.2-11.8 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 21.0 | 34.6 | 2.4 | 3.8 | 0.4 | 0.6 | 0.4 | 0.5 | 23.8 | 12.7 | 10.6-15.3 | 24.2 | 9.7 | 8.0-11.6 |
| V Retinoblastoma | 7.0 | 11.5 | 0.2 | 0.3 | 0.0 | 0.0 | 0.2 | 0.3 | 7.2 | 3.9 | 2.7-5.4 | 7.4 | 3.0 | 2.1-4.1 |
| VI Renal tumors | 12.8 | 21.1 | 4.0 | 6.3 | 1.8 | 2.7 | 1.4 | 1.9 | 18.6 | 9.8 | 7.9-12.1 | 20.0 | 7.8 | 6.4-9.5 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 12.8 | 21.1 | 3.8 | 6.0 | 0.8 | 1.2 | 0.0 | 0.0 | 17.4 | 9.2 | 7.4-11.4 | 17.4 | 6.9 | 5.5-8.5 |
| VII Hepatic tumors | 5.0 | 8.2 | 0.8 | 1.3 | 0.2 | 0.3 | 1.2 | 1.6 | 6.0 | 3.2 | 2.2-4.6 | 7.2 | 2.8 | 2.0-3.9 |
| VII(a) Hepatoblastoma and mesenchymal tumors of liver | 4.6 | 7.6 | 0.8 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | 2.9 | 1.9-4.2 | 5.4 | 2.2 | 1.4-3.1 |
| VIII Malignant bone tumors | 0.4 | 0.7 | 2.6 | 4.1 | 12.2 | 18.3 | 15.2 | 20.4 | 15.2 | 7.8 | 6.2-9.8 | 30.4 | 11.0 | 9.3-12.9 |
| VIII(a) Osteosarcoma | 0.0 | 0.0 | 1.2 | 1.9 | 7.6 | 11.4 | 8.0 | 10.8 | 8.8 | 4.5 | 3.3-6.1 | 16.8 | 6.1 | 4.9-7.5 |
| VIII(c) Ewing tumor and related sarcomas of bone | 0.4 | 0.7 | 1.4 | 2.2 | 4.2 | 6.3 | 4.0 | 5.4 | 6.0 | 3.1 | 2.1-4.4 | 10.0 | 3.7 | 2.7-4.8 |
| IX Soft tissue and other extraosseous sarcomas | 8.4 | 13.8 | 5.2 | 8.2 | 9.4 | 14.1 | 14.2 | 19.1 | 23.0 | 12.1 | 10.0-14.5 | 37.2 | 13.8 | 11.9-16.0 |
| IX(a) Rhabdomyosarcoma | 5.4 | 8.9 | 2.6 | 4.1 | 3.6 | 5.4 | 5.2 | 7.0 | 11.6 | 6.1 | 4.6-7.9 | 16.8 | 6.3 | 5.0-7.8 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 4.4 | 7.3 | 2.6 | 4.1 | 5.2 | 7.8 | 18.4 | 24.7 | 12.2 | 6.4 | 4.9-8.2 | 30.6 | 11.0 | 9.3-12.9 |
| X(a) Intracranial and intraspinal germ cell tumor | 1.0 | 1.6 | 0.8 | 1.3 | 2.2 | 3.3 | 1.8 | 2.4 | 4.0 | 2.1 | 1.3-3.2 | 5.8 | 2.2 | 1.5-3.1 |
| X(c) Malignant gonadal germ cell tumor | 0.6 | 1.0 | 1.6 | 2.5 | 2.8 | 4.2 | 14.2 | 19.1 | 5.0 | 2.6 | 1.7-3.8 | 19.2 | 6.8 | 5.5-8.3 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 1.6 | 2.6 | 3.2 | 5.0 | 25.0 | 37.5 | 61.8 | 83.1 | 29.8 | 15.3 | 13.0-18.0 | 91.6 | 32.4 | 29.5-35.5 |
| XI(b) Thyroid carcinoma | 0.4 | 0.7 | 0.4 | 0.6 | 10.4 | 15.6 | 37.0 | 49.8 | 11.2 | 5.7 | 4.3-7.4 | 48.2 | 16.8 | 14.8-19.1 |
| XI(d) Malignant melanoma | 1.0 | 1.6 | 0.8 | 1.3 | 2.8 | 4.2 | 4.8 | 6.5 | 4.6 | 2.4 | 1.5-3.6 | 9.4 | 3.4 | 2.5-4.5 |
| XII Other and unspecified malignant neoplasms | 1.6 | 2.6 | 0.4 | 0.6 | 0.6 | 0.9 | 1.4 | 1.9 | 2.6 | 1.4 | 0.7-2.3 | 4.0 | 1.5 | 0.9-2.3 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
